Back to Authors

Mehnert, Janice M.

https://orcid.org/0000-0001-9492-9264

A5101765112 | I102322142

Mayo Clinic

Rutgers, The State University of New Jersey

Citations 2

433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial

Regular and young investigator award abstracts | November 9, 2020 | Volume: No volume available | Issue: No issue available | Pages: A263.2-A264

10.1136/jitc-2020-sitc2020.0433

Model-based analysis of the relationship between pembrolizumab (MK-3475) exposure and efficacy in patients with advanced or metastatic melanoma.

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3068-3068

10.1200/jco.2015.33.15_suppl.3068